The trading price of Yield10 Bioscience Inc (NASDAQ:YTEN) closed higher on Thursday, March 29, closing at $0.38, 1.31% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.29 and a 52-week low of $0.18. Over the past month, the stock has gained 49.02% in value.
Yield10 Bioscience Inc, whose market valuation is $4.55 million at the time of this writing, is expected to release its quarterly earnings report Apr 01, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.3 per share this quarter, however they have predicted annual earnings per share of -$1.99 for 2023 and -$1.19 for 2024. It means analysts are expecting annual earnings per share growth of 27.90% this year and 40.20% next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $80k. The company’s revenue is forecast to drop by -82.20% over what it did in 2023.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Yield10 Bioscience Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest YTEN has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that YTEN’s price is currently 33.86% off the SMA20 and 43.47% off the SMA50. The RSI metric on the 14-day chart is currently showing 63.22, and weekly volatility stands at 22.55%. When measured over the past 30 days, the indicator reaches 17.72%. Yield10 Bioscience Inc (NASDAQ:YTEN)’s beta value is currently sitting at 1.59, while the Average True Range indicator is currently displaying 0.07.
To see how Yield10 Bioscience Inc stock has been performing in comparison to its peers in the industry, here are the numbers: YTEN stock’s performance was 1.31% in the latest trading, and -85.61% in the past year.
An evaluation of the daily trading volume of Yield10 Bioscience Inc (NASDAQ:YTEN) indicates that the 3-month average is 4.48 million. However, this figure has increased over the past 10 days to an average of 14.56 million.
Currently, records show that 11.98 million of the company’s shares remain outstanding. The insiders hold 18.81% of outstanding shares, whereas institutions hold 5.07%. The stats also highlight that short interest as of Mar 15, 2024, stood at 0.24 million shares, resulting in a short ratio of 0.98 at that time. From this, we can conclude that short interest is 2.00% of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 0.35 million. However, since the stock’s price has seen 58.80% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
